Select Page
2015, Volume 8, Issue 4, pp 566 – 567
Voiculescu OB *
Voinea LM **
* Department of Cellular and Molecular Medicine, “Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania
** Department of Ophthalmology, University Emergency Hospital Bucharest, Romania
Correspondence to: Olivia-Beatrice Voiculescu, MD, PhD student Department of Cellular and Molecular Medicine, “Carol Davila” University of Medicine and Pharmacy, 8 Eroilor Sanitari Bld., Code 050474, District 5, Bucharest, Romania Mobile phone: +40728 899 320, E-mail: [email protected]
Corneal neovascularization is a serious condition that may arise secondary to chemical burns, ischemia, infection, trauma, and inflammation and represents a major cause of blindness. This study investigated the efficacy of topical application of infliximab [tumor necrosis factor-a (TNF-a) monoclonal antibody] in the treatment of corneal neovascularization in the rabbit model.
PMC ID: 4656973
PubMed ID: 26664491
DOI:
Article Publishing Date (print): 2015-Oct-Dec
Available Online:
ISSN Printing: 1844-122X
ISSN Online: 1844-3117
Journal Title: Journal of Medicine and Life
Copyright License: Open Access
This article is distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/